𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma : Results of a Phase II study

✍ Scribed by Jaffer A. Ajani; Jackie Baker; Peter W. T. Pisters; Linus Ho; Paul F. Mansfield; Barry W. Feig; Chusilp Charnsangavej

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
138 KB
Volume
94
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Extended safety and efficacy data on S-1
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study
✍ Heinz-Joseph Lenz; Fa-Chyi Lee; Daniel G. Haller; Deepti Singh; Al B. Benson III πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

## Abstract ## BACKGROUND. S‐1 is a promising oral fluoropyrimidine. The authors obtained extended Phase II safety and efficacy data in a multicenter setting for the S‐1 plus cisplatin combination: The experimental arm of the global Phase III First‐Line Advanced Gastric Cancer Study (FLAGS) is bei

Preoperative induction of CPT-11 and cis
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction
✍ Jaffer A. Ajani; Garrett Walsh; Ritsuko Komaki; Jeff Morris; Stephen G. Swisher; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 96 KB

## Abstract ## BACKGROUND Patients with localized esophageal carcinoma often develop locoregional and distant disease recurrence. The current study investigated the outcome of a new chemotherapy combination as induction therapy before chemoradiotherapy. ## METHODS Forty‐three patients with resec

Treatment of patients with advanced gast
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen : Two parallel randomized phase II studies
✍ Carlo Barone; Domenico C. Corsi; Carmelo Pozzo; Alessandra Cassano; Tecla Fontan πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

370 mg/m 2 , on Days 1-5 and 36 others in Study B received epirubicin, 30 mg/m 2 , cina Interna e Geriatria, Universita `Cattolica del on Days 1 and 5; etoposide, 100 mg/m 2 , on Days 1, 3, and 5; cisplatin, 30 mg/m 2 , S. Cuore, Rome, Italy. on Days 2 and 4; and lonidamine, 150 mg/day. ## RESULTS